Autopsy report · NCT02511379

Clinical Evaluation of Systane® Balance in Dry Eye Subjects

“Discontinuation of product development”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 months before it started.
• Ran for about 7 months before it stopped.
• 14 participants enrolled.
• Results were posted on the registry 2 years 3 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Alcon Research

Sponsor type

Industry

Conditions

Dry Eye

Interventions

Propylene Glycol 0.6% eye drops

Participants

14

Trials that died the same way

• A Clinical Investigation to Assess the Effectiveness of Benzocaine Condoms in Healthy Adult Men
  “Change of the product development strategy” (70% match in meaning)
• Safety and Pharmacokinetics of UV-4B Solution Administered Orally as Multiple Ascending Doses to Healthy Subjects
  “Product development halted for business reasons.” (69% match in meaning)
• Safety and Tolerability of I-040302 in Children and Young Adults With Solitary Bone Cysts
  “Stopped before any site initiation or any recruitment due to change in overall product development plan” (64% match in meaning)
• A Study to Compare the Efficacy and Safety of JHL1101 Versus Rituximab in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL)
  “The development was stopped due to company's strategy consideration” (63% match in meaning)
• Feasibility and Impact of Volume Targeted Ventilation in the Delivery Room
  “Discontinuation of the study Product by manufacturer” (63% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.